A separate study published Wednesday found dose reduction methods in chest tomosynthesis dramatically impacted image clarity, highlighting the difficulties with cutting patients' exposure.

As the “panic-demic” descended on the U.S. and Canada in March and April, older adults (ages 60 and up) coped better with the stress than both young adults (18–39 years old) and middle agers (40–59).

Such testing typically makes the most sense when patients have a confirmed diagnosis of an inherited cardiovascular disease or an abnormality has already been identified.

Researchers explored everything from waitlist additions to deceased donor recoveries, sharing their findings in JAMA Cardiology. 

That’s according to a new analysis published in the European Journal of Internal Medicine.

Normal scores on thinking and memory tests at the start of a 14-year-long study were associated with fewer problems later in life, regardless of amyloid brain plaques.

Plus, new CT scanner drapes, Nuance's latest AI Marketplace addition, and several firms raise millions in capital. 

The wearable devices were designed to detect such conditions as cardiovascular disease, coronary artery disease and ischemic heart disease.

There’s good news and bad news from the COVID-19 beat. For the bad news, look anywhere news is disseminated. For the good, start with this compact but formidable roundup.  

This new analysis of the ODYSSEY OUTCOMES trial includes data from more than 18,000 patients.